GSK's cervical cancer vaccine to be sold OTC for £405 in the UK
This article was originally published in Scrip
Executive Summary
The UK pharmacy chain Boots is to sell an over-the-counter, three-injection course of GlaxoSmithKline's cervical cancer vaccine, Cervarix, at 134 of its 2,500 UK stores. Each injection will cost £135, with a total cost of £405.